NDAINTRAVENOUSPOWDERPriority Review
Approved
May 2020
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
20
Clinical Trials (5)
Study Evaluating the Efficacy and Safety of Artesunate
Started Aug 2025
Evaluation of Artesunate in Infants Being Treated for Severe Malaria
Started Oct 2024
Artesunate Pessaries (Vaginal Inserts) for Cervical Precancer in Kenya
Started Mar 2024
17 enrolled
Cervix CancerCervix NeoplasmPrecancerous Conditions+1 more
Study to Compare Feasibility of 1-step Injectable Artesunate vs. Conventional 2-step Injectable Artesunate
Started Jul 2022
Observational Study of the Safety of Intravenous Artesunate Treatment of Pregnant Women and Their Infants
Started Jun 2022
Loss of Exclusivity
LOE Date
Feb 16, 2044
218 months away
Patent Expiry
Feb 16, 2044
Exclusivity Expiry
May 26, 2027
Patent Records (1)
| Patent # | Expiry | Type | Use Code |
|---|---|---|---|
| 12121506 | Feb 16, 2044 | Product | — |
Company
Amivas
Ireland - Waterford
External Resources